Hajj Rodolphe, Baranek Thomas, Le Naour Richard, Lesimple Pierre, Puchelle Edith, Coraux Christelle
Institut National de Santé et de Recherche Médicale Unité 514, Centre Hospitalier Universitaire Maison Blanche, Reims, France.
Stem Cells. 2007 Jan;25(1):139-48. doi: 10.1634/stemcells.2006-0288. Epub 2006 Sep 28.
In numerous airway diseases, such as cystic fibrosis, the epithelium is severely damaged and must regenerate to restore its defense functions. Although the human airway epithelial stem cells have not been identified yet, we have suggested recently that epithelial stem/progenitor cells exist among both human fetal basal and suprabasal cell subsets in the tracheal epithelium. In this study, we analyzed the capacity of human adult basal cells isolated from human adult airway tissues to restore a well-differentiated and functional airway epithelium. To this end, we used the human-specific basal cell markers tetraspanin CD151 and tissue factor (TF) to separate positive basal cells from negative columnar cells with a FACSAria cell sorter. Sorted epithelial cells were seeded into epithelium-denuded rat tracheae that were grafted subcutaneously in nude mice and on collagen-coated porous membranes, where they were grown at the air-liquid interface. Sorted basal and columnar populations were also analyzed for their telomerase activity, a specific transit-amplifying cell marker, by the telomeric repeat amplification protocol assay. After cell sorting, the pure and viable CD151/TF-positive basal cell population proliferated on plastic and adhered on epithelium-denuded rat tracheae, as well as on collagen-coated porous membranes, where it was able to restore a fully differentiated mucociliary and functional airway epithelium, whereas viable columnar negative cells did not. Telomerase activity was detected in the CD151/TF-positive basal cell population, but not in CD151/TF-negative columnar cells. These results demonstrate that human adult basal cells are at least airway surface transit-amplifying epithelial cells.
在许多气道疾病中,如囊性纤维化,上皮细胞会受到严重损伤,必须再生以恢复其防御功能。尽管人类气道上皮干细胞尚未被鉴定出来,但我们最近提出,上皮干细胞/祖细胞存在于人类胎儿气管上皮的基底细胞和基底上层细胞亚群中。在本研究中,我们分析了从成人气道组织中分离出的成人基底细胞恢复分化良好且功能正常的气道上皮的能力。为此,我们使用人类特异性基底细胞标志物四跨膜蛋白CD151和组织因子(TF),通过FACSAria细胞分选仪将阳性基底细胞与阴性柱状细胞分离。将分选后的上皮细胞接种到去上皮的大鼠气管中,这些气管被皮下移植到裸鼠体内以及胶原包被的多孔膜上,在气液界面处生长。还通过端粒重复序列扩增协议分析对分选后的基底细胞群和柱状细胞群进行端粒酶活性分析,端粒酶活性是一种特定的过渡增殖细胞标志物。细胞分选后,纯的且有活力的CD151/TF阳性基底细胞群在塑料上增殖,并附着在去上皮的大鼠气管以及胶原包被的多孔膜上,在那里它能够恢复完全分化的黏液纤毛和功能正常的气道上皮,而有活力的柱状阴性细胞则不能。在CD151/TF阳性基底细胞群中检测到了端粒酶活性,而在CD151/TF阴性柱状细胞中未检测到。这些结果表明,成人基底细胞至少是气道表面的过渡增殖上皮细胞。